Join to View Full Profile
530 NE Glen Oak Ave1106Peoria, IL 61637
Phone+1 309-624-5419
Fax+1 312-942-0729
Dr. Chebrolu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Praneeth Chebrolu is the Director of Clinical Research in Peoria, IL. Dr. Chebrolu received medical degree from NTR University of Health Sciences, India with a masters in Clinical Research from Rush University in Chicago and has extensive Drug Development experience in areas of Oncology, Neurology, COVID-19, and PASC
Education & Training
Rush University Medical Center MS, Clinical Research , 2015 - 2018- OtherClass of 2011, MBBS
Clinical Trials
- Dendritic Cell Cancer Vaccine for High-grade Glioma Start of enrollment: 2010 Apr 01
- A Phase 3 Study of Tanezumab for Chronic Low Back Pain Start of enrollment: 2015 Aug 18
- An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation Start of enrollment: 2015 Dec 30
- Join now to see all
Publications & Presentations
Other
- Survival Analysis of Newly Diagnosed Glioblastoma Patients on Adjuvant Treatment with Temozolomide ≥ Six CyclesPraneeth Chebrolu, ProQuest
https://search-proquest-com.ezproxy.rush.edu/docview/2039182028/6123CCB292894632PQ/8?accountid=28534
4/2018
Grant Support
- Rush Translation Science Consortium - COVID19Rush University2020–Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
